Cargando…
Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
• CALLA (NCT03830866) is a randomized, international, double-blind, placebo-controlled study. • Immunotherapy-naïve patients with adenocarcinoma or cervical carcinoma are being enrolled. • CALLA is one of the largest trials in this patient population.
Autores principales: | Monk, Bradley J., Mayadev, Jyoti, Nunes, Ana T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906726/ https://www.ncbi.nlm.nih.gov/pubmed/31867430 http://dx.doi.org/10.1016/j.gore.2019.100506 |
Ejemplares similares
-
Reply to letter to the editor
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2020) -
Letter to the editor: Reply
por: Shim, Jung-Woo, et al.
Publicado: (2021) -
Reply to Lee et al.
por: Wang, Fei, et al.
Publicado: (2022) -
Authors’ reply to Hansel’s letter to the editor
por: Kotani, Yuki, et al.
Publicado: (2023) -
Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
por: Cavalcante, Marcelo Borges, et al.
Publicado: (2020)